Proficio Capital Partners LLC purchased a new stake in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 1,627 shares of the semiconductor company’s stock, valued at approximately $726,000.
A number of other institutional investors and hedge funds also recently bought and sold shares of the business. Foronjy Financial LLC lifted its position in Synopsys by 5.2% during the 4th quarter. Foronjy Financial LLC now owns 446 shares of the semiconductor company’s stock worth $210,000 after buying an additional 22 shares in the last quarter. AGH Wealth Advisors LLC lifted its position in shares of Synopsys by 4.4% during the first quarter. AGH Wealth Advisors LLC now owns 569 shares of the semiconductor company’s stock worth $226,000 after purchasing an additional 24 shares in the last quarter. Hardy Reed LLC grew its stake in shares of Synopsys by 0.8% during the fourth quarter. Hardy Reed LLC now owns 3,309 shares of the semiconductor company’s stock valued at $1,554,000 after purchasing an additional 25 shares during the last quarter. Annis Gardner Whiting Capital Advisors LLC increased its holdings in shares of Synopsys by 16.9% in the fourth quarter. Annis Gardner Whiting Capital Advisors LLC now owns 180 shares of the semiconductor company’s stock valued at $85,000 after purchasing an additional 26 shares in the last quarter. Finally, MCF Advisors LLC raised its position in Synopsys by 17.8% in the 4th quarter. MCF Advisors LLC now owns 172 shares of the semiconductor company’s stock worth $81,000 after purchasing an additional 26 shares during the last quarter. Institutional investors and hedge funds own 85.47% of the company’s stock.
Insider Buying and Selling
In other Synopsys news, insider Geus Aart De sold 25,000 shares of the stock in a transaction on Friday, August 28th. The shares were sold at an average price of $445.55, for a total value of $11,138,750.00. Following the sale, the insider directly owned 120,421 shares in the company, valued at approximately $53,653,576.55. This trade represents a 17.19% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Shelagh Glaser sold 3,394 shares of the business’s stock in a transaction on Friday, June 12th. The shares were sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the completion of the transaction, the chief financial officer directly owned 14,358 shares of the company’s stock, valued at $6,461,387.16. This trade represents a 19.12% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 42,997 shares of company stock valued at $19,368,311 in the last 90 days. 0.56% of the stock is owned by insiders.
Synopsys Trading Down 5.6%
Synopsys (NASDAQ:SNPS – Get Free Report) last issued its earnings results on Wednesday, August 26th. The semiconductor company reported $3.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.67 by $0.24. The firm had revenue of $2.48 billion for the quarter, compared to analysts’ expectations of $2.44 billion. Synopsys had a return on equity of 6.24% and a net margin of 11.43%.The company’s revenue was up 42.4% compared to the same quarter last year. During the same quarter last year, the business earned $3.39 earnings per share. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. Research analysts forecast that Synopsys, Inc. will post 11 EPS for the current year.
Analyst Ratings Changes
SNPS has been the topic of a number of recent research reports. Weiss Ratings upgraded Synopsys from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, August 27th. Needham & Company LLC reaffirmed a “buy” rating and set a $580.00 price target on shares of Synopsys in a research note on Thursday, August 27th. Morgan Stanley lowered their price objective on Synopsys from $525.00 to $500.00 and set an “equal weight” rating for the company in a research report on Wednesday, August 19th. Robert W. Baird raised Synopsys from a “neutral” rating to an “outperform” rating and boosted their price objective for the stock from $558.00 to $560.00 in a report on Thursday, August 27th. Finally, Piper Sandler upgraded shares of Synopsys from a “neutral” rating to an “overweight” rating and upped their target price for the company from $450.00 to $550.00 in a research report on Tuesday, June 23rd. Twelve analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $561.28.
View Our Latest Report on Synopsys
Synopsys News Roundup
Here are the key news stories impacting Synopsys this week:
- Positive Sentiment: Wall Street’s mean price target implies approximately 25.4% upside. Analysts’ improving earnings estimates provide a more meaningful bullish signal than the target-price average alone. Wall Street Analysts See a 25.39% Upside in Synopsys
- Positive Sentiment: Analyst sentiment remains broadly favorable, with a “Moderate Buy” consensus, 12 Buy ratings, and recent price targets as high as $580. Robert W. Baird also upgraded the stock to Outperform and raised its target to $560. Is It Worth Investing in Synopsys Based on Wall Street’s Bullish Views?
- Positive Sentiment: A bullish investor article highlights Synopsys’ 42.4% year-over-year quarterly revenue growth, recent earnings beat, and potential for the market to be underestimating its AI-related chip-design opportunity relative to peers. The Market May Be Underestimating This AI Chip-Design Stock
- Neutral Sentiment: A decade-long investment retrospective emphasizes Synopsys’ substantial long-term returns, but it is backward-looking and is unlikely to be a major near-term trading catalyst. Here’s How Much You’d Have If You Invested $1000 in Synopsys a Decade Ago
- Negative Sentiment: Executive Chair Aart de Geus sold 25,000 shares for approximately $11.1 million, reducing his holdings by 17.19%. The transaction was made under a pre-arranged Rule 10b5-1 plan, which lessens—but does not eliminate—the negative signaling effect. Synopsys Insider Geus Aart De Sells 25,000 Shares
- Negative Sentiment: Semiconductor stocks broadly came under pressure as a global bond selloff pushed long-term yields higher. Rising yields can weigh particularly heavily on high-multiple growth stocks such as Synopsys, which trades at an elevated valuation. Semiconductor Stocks Slide as Global Bond Selloff Lifts Yields
Synopsys Company Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Featured Articles
- Five stocks we like better than Synopsys
- Dutch Bros Sell-Off Creates a Growth Opportunity
- NVIDIA’s MediaTek Bet Shows How It Plans to Defend Its AI Moat
- Is Abercrombie & Fitch’s Hot Streak Just Getting Started?
- Medtronic’s Stars Are Aligning for a Price Recovery
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
